USPTO serial 77478756
THE POWER OF REVERSIBLE PROTEASOME INHIBITION
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- ALTREE, NICHOLAS
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with THE POWER OF REVERSIBLE PROTEASOME INHIBITION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nancy C. DiConza
NANCY C. DICONZA FROSS ZELNICK LEHRMAN & ZISSU, P.C.866 UNITED NATIONS PLZNEW YORK, NY 10017-1822UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | prescription pharmaceutical preparations for use in the diagnosis or treatment of human diseases and disorders, namely, oncologic diseases and disorders, excluding analgesics | ACTIVE | — |
| 040 | research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic, pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, namely, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields; consultation services, namely, providing consultation to others via global, national, and local computer networks in the fields of life sciences, pharmacogenomics, diagnostics, clinical trial design and biotechnology; providing on-line computer databases via global, national, and local computer networks in the fields of life sciences, pharmacogenomics, diagnostics, clinical trial design and biotechnology | ACTIVE | — |
| 044 | medical services and medical diagnostic services, namely, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Millennium Pharmaceuticals, Inc.
- Other trademarks owned by Millennium Pharmaceuticals, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 044
- Similar marks named THE POWER OF REVERSIBLE PROTEASOME INHIBITION
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 23, 2012 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 23, 2012 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 16, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Jun 15, 2011 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jun 10, 2011 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jun 10, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 27, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Nov 26, 2010 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 23, 2010 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 23, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 10, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Jun 9, 2010 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 2, 2010 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 2, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 21, 2010 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 21, 2010 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 4, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 4, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 4, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 4, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 4, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 23, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 30, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 10, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 26, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 26, 2008 | ALIE | ASSIGNED TO LIE | — |
| Aug 16, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 15, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| May 23, 2008 | NWAP | NEW APPLICATION ENTERED | — |